ArticleDiscover oncology2025
MTHFD2 marks pemetrexed resistance in pulmonary adenocarcinoma with EGFR wild type.
Sha Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleDiscover oncology2025
Sha Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.